156 related articles for article (PubMed ID: 24704061)
1. Metabolomic prediction of fetal congenital heart defect in the first trimester.
Bahado-Singh RO; Ertl R; Mandal R; Bjorndahl TC; Syngelaki A; Han B; Dong E; Liu PB; Alpay-Savasan Z; Wishart DS; Nicolaides KH
Am J Obstet Gynecol; 2014 Sep; 211(3):240.e1-240.e14. PubMed ID: 24704061
[TBL] [Abstract][Full Text] [Related]
2. Urine metabolomic biomarkers for prediction of isolated fetal congenital heart defect.
Friedman P; Yilmaz A; Ugur Z; Jafar F; Whitten A; Ustun I; Turkoglu O; Graham S; Bahado Singh R
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6380-6387. PubMed ID: 33944672
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic analysis for first-trimester Down syndrome prediction.
Bahado-Singh RO; Akolekar R; Mandal R; Dong E; Xia J; Kruger M; Wishart DS; Nicolaides K
Am J Obstet Gynecol; 2013 May; 208(5):371.e1-8. PubMed ID: 23313728
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic analysis for first-trimester trisomy 18 detection.
Bahado-Singh RO; Akolekar R; Chelliah A; Mandal R; Dong E; Kruger M; Wishart DS; Nicolaides K
Am J Obstet Gynecol; 2013 Jul; 209(1):65.e1-9. PubMed ID: 23535240
[TBL] [Abstract][Full Text] [Related]
5. First-trimester metabolomic prediction of stillbirth.
Bahado-Singh RO; Syngelaki A; Mandal R; Han B; Li L; Bjorndahl TC; Wang N; Maulik D; Dong E; Turkoglu O; Tseng CL; Zeb A; Redman M; Wishart DS; Nicolaides KH
J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3435-3441. PubMed ID: 29712497
[No Abstract] [Full Text] [Related]
6. First-trimester metabolomic detection of late-onset preeclampsia.
Bahado-Singh RO; Akolekar R; Mandal R; Dong E; Xia J; Kruger M; Wishart DS; Nicolaides K
Am J Obstet Gynecol; 2013 Jan; 208(1):58.e1-7. PubMed ID: 23159745
[TBL] [Abstract][Full Text] [Related]
7. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
Prenat Diagn; 2009 Jun; 29(6):570-7. PubMed ID: 19266536
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Validation of Potential Serum Biomarkers for Pediatric Patients with Congenital Heart Diseases by Metabolomics.
Yu M; Sun S; Yu J; Du F; Zhang S; Yang W; Xiao J; Xie B
J Proteome Res; 2018 Oct; 17(10):3517-3525. PubMed ID: 30207476
[TBL] [Abstract][Full Text] [Related]
9. Incidence and outcome of prenatally diagnosed, chromosomally normal congenital heart defects in Singapore.
Dhanardhono T; Thia E; Wei X; Saktini F; Dewi PK; Yeo GS
Singapore Med J; 2012 Oct; 53(10):643-7. PubMed ID: 23112014
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging in the normal fetal heart and in congenital heart disease.
Votino C; Jani J; Damry N; Dessy H; Kang X; Cos T; Divano L; Foulon W; De Mey J; Cannie M
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):322-9. PubMed ID: 21837757
[TBL] [Abstract][Full Text] [Related]
11. Ambient temperature and congenital heart defects.
Agay-Shay K; Friger M; Linn S; Peled A; Amitai Y; Peretz C
Hum Reprod; 2013 Aug; 28(8):2289-97. PubMed ID: 23739216
[TBL] [Abstract][Full Text] [Related]
12. Prepregnancy body mass index and congenital heart defects among offspring: a population-based study.
Madsen NL; Schwartz SM; Lewin MB; Mueller BA
Congenit Heart Dis; 2013; 8(2):131-41. PubMed ID: 22967199
[TBL] [Abstract][Full Text] [Related]
13. Integrated Proteomic and Metabolomic prediction of Term Preeclampsia.
Bahado-Singh R; Poon LC; Yilmaz A; Syngelaki A; Turkoglu O; Kumar P; Kirma J; Allos M; Accurti V; Li J; Zhao P; Graham SF; Cool DR; Nicolaides K
Sci Rep; 2017 Nov; 7(1):16189. PubMed ID: 29170520
[TBL] [Abstract][Full Text] [Related]
14. Role of nutrition in pregnancy with phenylketonuria and birth defects.
Matalon KM; Acosta PB; Azen C
Pediatrics; 2003 Dec; 112(6 Pt 2):1534-6. PubMed ID: 14654660
[TBL] [Abstract][Full Text] [Related]
15. A metabolomic profile is associated with the risk of incident coronary heart disease.
Vaarhorst AA; Verhoeven A; Weller CM; Böhringer S; Göraler S; Meissner A; Deelder AM; Henneman P; Gorgels AP; van den Brandt PA; Schouten LJ; van Greevenbroek MM; Merry AH; Verschuren WM; van den Maagdenberg AM; van Dijk KW; Isaacs A; Boomsma D; Oostra BA; van Duijn CM; Jukema JW; Boer JM; Feskens E; Heijmans BT; Slagboom PE
Am Heart J; 2014 Jul; 168(1):45-52.e7. PubMed ID: 24952859
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects.
Chen L; Gu H; Li J; Yang ZY; Sun X; Zhang L; Shan L; Wu L; Wei X; Zhao Y; Ma W; Zhang H; Cao S; Huang T; Miao J; Yuan Z
Sci Rep; 2016 Jan; 6():19248. PubMed ID: 26750556
[TBL] [Abstract][Full Text] [Related]
17. Study on the Potential Biomarkers of Maternal Urine Metabolomics for Fetus with Congenital Heart Diseases Based on Modified Gas Chromatograph-Mass Spectrometer.
Xie D; Luo Y; Xiong X; Lou M; Liu Z; Wang A; Xiong L; Kong F; Wang Y; Wang H
Biomed Res Int; 2019; 2019():1905416. PubMed ID: 31198782
[TBL] [Abstract][Full Text] [Related]
18. Association between maternal chronic conditions and congenital heart defects: a population-based cohort study.
Liu S; Joseph KS; Lisonkova S; Rouleau J; Van den Hof M; Sauve R; Kramer MS;
Circulation; 2013 Aug; 128(6):583-9. PubMed ID: 23812182
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive screening for congenital heart defects using a serum metabolomics approach.
Troisi J; Cavallo P; Richards S; Symes S; Colucci A; Sarno L; Landolfi A; Scala G; Adair D; Ciccone C; Maruotti GM; Martinelli P; Guida M
Prenat Diagn; 2021 May; 41(6):743-753. PubMed ID: 33440021
[TBL] [Abstract][Full Text] [Related]
20. The association between congenital heart disease and Down syndrome in prenatal life.
Paladini D; Tartaglione A; Agangi A; Teodoro A; Forleo F; Borghese A; Martinelli P
Ultrasound Obstet Gynecol; 2000 Feb; 15(2):104-8. PubMed ID: 10775990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
